TWI519642B - Novel dekkera bruxellensis - Google Patents
Novel dekkera bruxellensis Download PDFInfo
- Publication number
- TWI519642B TWI519642B TW104109310A TW104109310A TWI519642B TW I519642 B TWI519642 B TW I519642B TW 104109310 A TW104109310 A TW 104109310A TW 104109310 A TW104109310 A TW 104109310A TW I519642 B TWI519642 B TW I519642B
- Authority
- TW
- Taiwan
- Prior art keywords
- resveratrol
- strain
- mutant
- bcrc
- medium
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本發明關於一種生產白藜蘆醇(resveratrol)的方法,且特別關於以微生物轉化生產白藜蘆醇的方法。 The present invention relates to a process for producing resveratrol, and in particular to a process for producing resveratrol by microbial conversion.
白藜蘆醇(resveratrol)為一種植物多酚,主要為植物受到環境逆境時如:外力傷害、UV過度照射。昆蟲及微生物入侵感染時所生成的抵禦機制,為一種植物抗菌素(phytoalexins)(Anastasiadi et al.,2012;Burns et al.,2002;Fremont,2000;Potrebko and Resurreccion,2009)。白藜蘆醇化學名稱為三羥基二苯乙烯(3,5,4’-trihydrozystibene)(Abbott et al.),最早於1940學者Takaoka由白藜蘆(white hellebore;Veratrum grandiflorum O.Loes)的根部分離出鑑定,隨後於1963由中國傳統中藥材-虎杖(Polygonum cuspidatum)的根莖部中亦被分離出有白藜蘆醇成分。白藜蘆醇除了於上述植物中被發現,其亦存在一些特定的植物中,如葡萄、藍莓等某些莓果類,或是花生及石榴等(Burns et al.,2002;Counet et al.,2006;Jerkovic et al.,2010;Manach et al.,2004;Tome-Carneiro et al.,2012;Wang,2012),然而這些的植物所含的白藜蘆醇含量差異很大,同時,在某些植物中白藜蘆醇會以糖苷(piceid;polydatin)的形式存在體內。 Resveratrol (resveratrol) is a plant polyphenol, mainly caused by environmental stress, such as: external damage, UV over-irradiation. The defense mechanism generated by insects and microbial invasion infections is a phytoalexins (Anastasiadi et al., 2012; Burns et al., 2002; Fremont, 2000; Potrebko and Resurreccion, 2009). The chemical name of resveratrol is 3,5,4'-trihydrozystibene (Abbott et al.), the earliest in 1940 scholar Takaoka by the root of white hellebore (Veratrum grandiflorum O.Loes) The identification was isolated, and then in 1963, the resveratrol component was also isolated from the rhizome of the traditional Chinese herbal medicine Polygonum cuspidatum . In addition to being found in the above plants, resveratrol also exists in certain plants, such as certain berries such as grapes and blueberries, or peanuts and pomegranates (Burns et al., 2002; Counet et al. , 2006; Jerkovic et al., 2010; Manach et al., 2004; Tome-Carneiro et al., 2012; Wang, 2012), however, the resveratrol content of these plants varies widely, and In some plants, resveratrol is present in the form of a glycidid (polydatin).
目前已知白藜蘆醇其具有抗老化、降低糖尿病、肝 病、心臟病、癌症及其他代謝症候群相關疾病的罹患機率,然而因其於植物中含量稀少且萃取不易,使其售價及應用上均受限制。 Resveratrol is currently known to have anti-aging, reduce diabetes, liver The risk of illness, heart disease, cancer and other metabolic syndrome-related diseases, however, due to its low content in plants and difficult extraction, its price and application are limited.
白藜蘆醇化合物有兩種異構物分別為順式(cis)與反式(trans)結構,反式結構才有生理活性,反式結構經UV照射後會變為順式結構而失去生理活性(Potrebko and Resurreccion,2009),於植物中白藜蘆醇會與糖結合形成較穩定的糖苷形式,糖苷形式有接單糖於不同位置(Counet et al.,2006;Jerkovic et al.,2010;Sun et al.,2010;Wang et al.,2007;Zhang et al.,2007),亦有同時接兩個單糖的形式,但在虎杖中主要以單糖接於3’-位置上的羥基形式居多數(Sun et al.,2010;Wang et al.,2007;吳佳穎,2007),這些不同的接糖形式主要為穩定白藜蘆醇於生物體內,於適當時機時生物體可直接轉化生成白藜蘆醇應用。 Resveratrol compounds have two isoforms, cis and trans, respectively. The trans structure has physiological activity, and the trans structure becomes cis-structure and loses its physiology after UV irradiation. Activity (Potrebko and Resurreccion, 2009), in plants, resveratrol binds to sugars to form a more stable glycoside form, with glycosides in different positions (Counet et al., 2006; Jerkovic et al., 2010) ; Sun et al., 2010; Wang et al., 2007; Zhang et al., 2007), also in the form of two monosaccharides, but in the knotweed, the monosaccharide is mainly attached to the 3'-position. The hydroxy form is predominant (Sun et al., 2010; Wang et al., 2007; Wu Jiaying, 2007). These different forms of glycosylation are mainly to stabilize resveratrol in living organisms, and the organism can be directly transformed at an appropriate timing. Generate resveratrol application.
目前生產白藜蘆醇的方法,有植物萃取法、化學合成法、植物轉化法以及微生物基因工程等,然而植物中白藜蘆醇主要經由酪胺酸與苯丙氨酸途徑合成,其中主要關鍵步驟為合成二苯乙烯合成酶(stilbene synthase)(Donnez et al.,2009),目前文獻所列以微生物基因工程生產白藜蘆醇的方式,可分為酵母菌與細菌兩部份(Donnez et al.,2009)。 At present, the methods for producing resveratrol include plant extraction, chemical synthesis, plant transformation, and microbial genetic engineering. However, resveratrol in plants is mainly synthesized by tyrosine and phenylalanine pathways. The step is to synthesize stilbene synthase (Donnez et al., 2009). The current literature lists microbial genetic engineering to produce resveratrol, which can be divided into yeast and bacteria (Donnez et Al., 2009).
文獻研究指出:目前萃取虎杖中白藜蘆醇方法主要有五種,分別以鹼萃取法(Alkaline extraction)、溶劑萃取法(Solvent extraction)、超音波輔助法(Ultrasonic extraction)、索式回流萃取(Soxhlet extraction)以及CO2超臨界流萃取法(SFE-CO2)(Benova et al.,2010;Cho et al.,2006;Du et al.,2007;Lei et al.,2007;吳佳穎,2007)。所有的萃取方法均有其優缺點,然而 就單純以萃取效果而言,超音波輔助法萃取效果最佳(Lei et al.,2007)。 Literature research indicates that there are currently five methods for extracting resveratrol from Polygonum cuspidatum, which are Alkaline extraction, Solvent extraction, Ultrasonic extraction, and cable reflux extraction. Soxhlet extraction) and CO 2 supercritical fluid extraction (SFE-CO2) (Benova et al., 2010; Cho et al., 2006; Du et al., 2007; Lei et al., 2007; Wu Jiaying, 2007). All extraction methods have their advantages and disadvantages, but ultrasonic extraction is the best in terms of extraction (Lei et al., 2007).
本發明提供一種以微生物轉化生產白藜蘆醇(resveratrol)的方法,包括:(a)提供一德克酵母屬(Dekkera)之酵母菌或其突變株與一基質,其中該基質包括白藜蘆醇前驅物或含有白藜蘆醇前驅物的一植物基質;(b)將該德克酵母屬之酵母菌或其突變株與該基質加入至一培養基中以形成一混合物;以及(c)對該混合物進行發酵,以使於該混合物中存在之該白藜蘆醇前驅物被該德克酵母屬之酵母菌或其突變株生物轉化而產生白藜蘆醇。 The present invention provides a method for producing resveratrol by microbial transformation, comprising: (a) providing a yeast of the genus Dekkera or a mutant thereof and a substrate, wherein the substrate comprises a white gourd An alcohol precursor or a plant substrate comprising a resveratrol precursor; (b) adding the yeast of the genus D. cerevisiae or the mutant thereof to the medium to form a mixture; and (c) The mixture is subjected to fermentation such that the resveratrol precursor present in the mixture is biotransformed by the yeast of the genus Dacillus or a mutant thereof to produce resveratrol.
本發明也提供一種新穎之布魯塞爾德克酵母菌(Dekkera bruxellensis)突變株,其於中華民國102年1月9日寄存於中華民國食品工業發展研究所生物資源保存及研究中心,寄存編號為BCRC 920084之布魯塞爾德克酵母菌。 The present invention also provides a novel mutant strain of Dekkera bruxellensis , which was deposited on January 9, 102, in the Center for Biological Resource Conservation and Research of the Republic of China Food Industry Development Institute, under the registration number BCRC 920084. Brussels Dick yeast.
第1A圖顯示,初步選擇之各菌株使用虎杖為基質之轉化生成白藜蘆醇的實驗結果。 Figure 1A shows the results of experiments in which the initially selected strains were transformed with polygonum cuspidatum to form resveratrol.
第1B圖顯示,初步選擇之各菌株使用石榴皮為基質之轉化生成白藜蘆醇的實驗結果。 Figure 1B shows the experimental results of the initial selection of each strain using pomegranate peel as a substrate to produce resveratrol.
第2圖顯示,不同之布魯塞爾德克酵母菌使用虎杖為基質之轉化生成白藜蘆醇的實驗結果。 Figure 2 shows the results of experiments in which different D. brucei were converted to resveratrol using the Polygonum cuspidatum substrate.
第3圖顯示,所挑選之12株突變株其於不同培養時間點產生的β-葡萄糖苷酶(β-glucosidase)量。 Figure 3 shows the amount of β-glucosidase produced by the 12 mutant strains selected at different culture time points.
第4A圖顯示利用5公升發酵槽並以虎杖為植物基質且以水、醋酸緩衝溶液或福格爾最小鹽類培養基(Vogel minimal salts medium,VMSM)來培養編號72號之突變株進行白藜蘆醇轉化生成之結果。 Figure 4A shows the use of a 5 liter fermenter with a Polygonum cuspidatum as the plant substrate and culture of the No. 72 mutant with water, acetic acid buffer solution or Vogel minimal salts medium (VMSM) for the white squash. The result of alcohol conversion.
第4B圖顯示利用20公升發酵槽並以虎杖為植物基質且以醋酸緩衝溶液來培養編號72號之突變株進行白藜蘆醇轉化生成之結果。 Fig. 4B shows the results of reconstitution of resveratrol by using a 20 liter fermentation tank and using a Polygonum cuspidatum as a plant substrate and culturing a mutant strain No. 72 with an acetic acid buffer solution.
在本發明一實施態樣中,本發明提供一種以上微生物轉化生產白藜蘆醇(resveratrol)的方法。本發明之以微生物轉化生產白藜蘆醇方法可包括下述步驟,但不限於此。 In one embodiment of the invention, the invention provides a method for the production of resveratrol by the above microorganisms. The method for producing resveratrol by microbial transformation of the present invention may include the following steps, but is not limited thereto.
首先,提供一德克酵母屬(Dekkera)之酵母菌或其突變株與一基質。上述基質可包括,但不限於,白藜蘆醇前驅物或含有白藜蘆醇前驅物的一植物基質。 First, a yeast of the genus Dekkera or a mutant thereof and a substrate are provided. The above substrate may include, but is not limited to, a resveratrol precursor or a plant substrate containing a resveratrol precursor.
上述德克酵母屬之酵母菌或其突變株可包括一布魯塞爾德克酵母菌(Dekkera bruxellensis)或其突變株,但不限於此。上述布魯塞爾德克酵母菌或其突變株的例子,可包括,布魯塞爾德克酵母菌BCRC 21440或其突變株等,但不限於此。又,布魯塞爾德克酵母菌BCRC 21440之突變株的例子則可包括,但不限於,於中華民國102年1月9日寄存於中華民國食品工業發展研究所生物資源保存及研究中心,寄存編號為BCRC 920084之布魯塞爾德 克酵母菌等。 The yeast of the genus Decobacteria or a mutant thereof may include, but is not limited to, Dekkera bruxellensis or a mutant thereof. Examples of the above-mentioned D. cerevisiae or a mutant thereof may include, but are not limited to, D. brucei BCRC 21440 or a mutant thereof. Further, examples of the mutant strain of D. brucei BCRC 21440 may include, but are not limited to, deposited in the Bioresource Conservation and Research Center of the Republic of China Food Industry Development Institute on January 9, 102, the registration number of BCRC 920084 of D. serrata and the like.
在一實施例中,於本發明之以微生物轉化生產白藜蘆醇的方法中所使用的德克酵母屬之酵母菌或其突變株可為布魯塞爾德克酵母菌BCRC 21440。在另一實施例中,於本發明之以微生物轉化生產白藜蘆醇的方法中所使用的德克酵母屬之酵母菌或其突變株可為,於中華民國102年1月9日寄存於中華民國食品工業發展研究所生物資源保存及研究中心,寄存編號為BCRC 920084之布魯塞爾德克酵母菌(此菌也於2013年7月11日寄存於德國微生物菌種保存中心(Deutsche Sammlung von Mikroorganismen und Zellkulturen,DSMZ),寄存編號為DSM 27483)。 In one embodiment, the yeast of the genus D. cerevisiae or the mutant thereof used in the method for producing resveratrol by microbial transformation of the present invention may be D. brucei BCRC 21440. In another embodiment, the yeast of the genus Dirkweed or the mutant thereof used in the method for producing resveratrol by microbial transformation of the present invention may be deposited on January 9, 102, the Republic of China. Bioresource Conservation and Research Center of the Republic of China Food Industry Development Institute, registered D. serrata of BCRC 920084 (this bacterium was also deposited with the German Collection of Microbial Species on July 11, 2013 (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ), registration number DSM 27483).
於本發明之以微生物轉化生產白藜蘆醇的方法中,上述白藜蘆醇前驅物可包括白藜蘆醇糖苷等,但不限於此,而白藜蘆醇糖苷的例子可包括,但不限於虎杖糖苷等。又,於本發明之以微生物轉化生產白藜蘆醇的方法中,上述含有白藜蘆醇前驅物的該植物基質的例子可包括,但不限於,虎杖、葡萄或葡萄皮、石榴或石榴皮、花生、可可、藍莓、桑葚、蔓越莓或、波蘿蜜等。在一實施例中,上述含有白藜蘆醇前驅物的植物基質可為虎杖,而含於虎杖之白藜蘆醇糖苷為虎杖糖苷。 In the method for producing resveratrol by microbial transformation of the present invention, the above resveratrol precursor may include resveratrol glycoside or the like, but is not limited thereto, and examples of the resveratrol glycoside may include, but not Limited to Polygonum glycosides and the like. Further, in the method of the present invention for producing resveratrol by microbial transformation, examples of the plant substrate containing the resveratrol precursor may include, but are not limited to, knotweed, grape or grape skin, pomegranate or pomegranate peel. , peanuts, cocoa, blueberries, mulberries, cranberries or bolognese. In one embodiment, the plant substrate containing the resveratrol precursor may be a Polygonum cuspidatum, and the resveratrol glycoside contained in Polygonum cuspidatum is a Polydatin.
在一特定實施例中,於本發明之以微生物轉化生產白藜蘆醇的方法中,所述基質為含有白藜蘆醇前驅物的植物基質。又,於此實施例中含有白藜蘆醇前驅物的植物基質的例子可為虎杖。 In a particular embodiment, in the method of the invention for producing resveratrol by microbial transformation, the substrate is a plant substrate comprising a resveratrol precursor. Further, an example of a plant substrate containing a resveratrol precursor in this embodiment may be a knotweed.
接著,在提供一德克酵母屬之酵母菌或其突變株與一基質之後,將上述德克酵母屬之酵母菌或其突變株與上述基質 加入至一培養基中以形成一混合物。 Next, after providing a yeast of the genus Decobacterium or a mutant thereof and a substrate, the above-mentioned yeast of the genus D. cerevisiae or a mutant thereof and the above-mentioned substrate It is added to a medium to form a mixture.
上述德克酵母屬之酵母菌或其突變株之添加量為培養基體積的1-65%。在一實施例中,上述德克酵母屬之酵母菌或其突變株之添加量為培養基體積的1-40%。又,上述基質之添加量為培養基體積的1-65%。在一實施例中,上述基質之添加量為培養基體積的1-40%。 The yeast of the genus Decobacteria or a mutant thereof is added in an amount of from 1 to 65% by volume of the medium. In one embodiment, the yeast of the genus Decobacteria or a mutant thereof is added in an amount of from 1 to 40% by volume of the medium. Further, the substrate is added in an amount of from 1 to 65% by volume of the medium. In one embodiment, the substrate is added in an amount of from 1 to 40% by volume of the medium.
又,適用於本發明之培養基的例子,可包括,水、醋酸緩衝溶液與福格爾最小鹽類培養基(Vogel minimal salts medium,VMSM)等,但不限於此。 Further, examples of the medium suitable for the present invention may include, but are not limited to, water, an acetic acid buffer solution, and a Vogel minimal salt medium (VMSM).
然後,將上述德克酵母屬之酵母菌或其突變株與上述基質加入至一培養基中以形成一混合物之後,對混合物進行發酵,以使於混合物中存在之白藜蘆醇前驅物被上述德克酵母屬之酵母菌或其突變株生物轉化而產生白藜蘆醇。 Then, after the above-mentioned yeast of the genus D. cerevisiae or the mutant thereof is added to a medium to form a mixture, the mixture is fermented so that the resveratrol precursor present in the mixture is obtained by the above-mentioned German The yeast of the genus Saccharomyces or its mutant is biotransformed to produce resveratrol.
上述發酵所進行之時間可為約12-72小時。在一實施例中,上述發酵所進行之時間可為約18-48小時。又,上述發酵可於約20-35℃之溫度進行。在一實施例中,上述發酵可於約23-30℃之溫度進行。 The fermentation can be carried out for a period of about 12 to 72 hours. In one embodiment, the fermentation can be carried out for a period of from about 18 to 48 hours. Further, the above fermentation can be carried out at a temperature of about 20 to 35 °C. In one embodiment, the above fermentation can be carried out at a temperature of about 23-30 °C.
另外,上述發酵可於一搖瓶或發酵槽中進行。 Alternatively, the above fermentation can be carried out in a shake flask or fermentation tank.
在一實施例中,於本發明之以微生物轉化生產白藜蘆醇的方法中,發酵於一發酵槽中進行,且該德克酵母屬之酵母菌之添加量為培養基體積的1-65%,而該基質之添加量為培養基體積的1-65%。又於此實施例中,上述發酵所進行之時間可為約18-48小時,而上述發酵可於約23-30℃之溫度進行。又,於此實施例中,基質為含有白藜蘆醇前驅物的該植物基質,而植物基質 可為虎杖或石榴皮等。 In one embodiment, in the method for producing resveratrol by microbial transformation according to the present invention, the fermentation is carried out in a fermenting tank, and the yeast of the genus Decobacter is added in an amount of 1-65% by volume of the medium. And the substrate is added in an amount of from 1 to 65% by volume of the medium. In still another embodiment, the fermentation may be carried out for a period of about 18 to 48 hours, and the fermentation may be carried out at a temperature of about 23 to 30 °C. Further, in this embodiment, the substrate is the plant substrate containing the resveratrol precursor, and the plant substrate It can be a knotweed or a pomegranate peel.
再者,在另一實施例中,本發明以微生物轉化生產白藜蘆醇的方法,於上述對混合物進行發酵,以使於混合物中存在之白藜蘆醇前驅物被上述德克酵母屬之酵母菌或其突變株生物轉化而產生白藜蘆醇的步驟之後,還可更包括一從該混合物中萃取白藜蘆醇的步驟。 Furthermore, in another embodiment, the present invention uses a method for microbial conversion to produce resveratrol, and the mixture is fermented as described above so that the resveratrol precursor present in the mixture is subjected to the above-mentioned D. After the step of biotransformation of the yeast or its mutant to produce resveratrol, a step of extracting resveratrol from the mixture may be further included.
而上述從該混合物中萃取白藜蘆醇的步驟,可包括下列步驟,但不限於此。 The above step of extracting resveratrol from the mixture may include the following steps, but is not limited thereto.
先將酒精加入於上述發酵後混合物中並進行超音波震盪以形成一萃取液。上述酒精可包括1-80%之酒精,在一實施例中,上述酒精為80%酒精。另外,所使用之酒精與上述混合物之體積比為1:5-1:20。在一實施例中,所使用酒精與上述混合物之體積比為1:10。 Alcohol is first added to the above-mentioned post-fermentation mixture and subjected to ultrasonic vibration to form an extract. The above alcohol may include 1-80% alcohol, and in one embodiment, the above alcohol is 80% alcohol. Further, the volume ratio of the alcohol used to the above mixture is 1:5-1:20. In one embodiment, the volume ratio of alcohol used to the above mixture is 1:10.
接著,在形成上述萃取液之後將上述萃取液進行乾燥,然後再加入水及乙醚以形成一水層與一乙醚層。所使用的水與上述經乾燥之萃取液的重量比為1:5-1:20。在一實施例中,所使用的水與上述經乾燥之萃取液的重量比為1:10。又,所使用的乙醚與上述經乾燥之萃取液的重量比為1:5-1:20。在一實施例中,所使用的乙醚與上述經乾燥之萃取液的重量比為1:10。 Next, after the formation of the above extract, the above extract was dried, and then water and diethyl ether were further added to form an aqueous layer and a diethyl ether layer. The weight ratio of water used to the above dried extract is 1:5-1:20. In one embodiment, the weight ratio of water used to the dried extract described above is 1:10. Further, the weight ratio of the diethyl ether to the above-mentioned dried extract is 1:5-1:20. In one embodiment, the weight ratio of diethyl ether used to the dried extract described above is 1:10.
然後,收集上述乙醚層並將上述乙醚層乾燥以獲得白藜蘆醇產物。 Then, the above ether layer was collected and the above ether layer was dried to obtain a resverat product.
另外,在本發明之另一實施態樣中,本發明提供一種新穎之布魯塞爾德克酵母菌突變株,其於中華民國102年1月9日寄存於中華民國食品工業發展研究所生物資源保存及研究中 心,寄存編號為BCRC 920084之布魯塞爾德克酵母菌。 In addition, in another embodiment of the present invention, the present invention provides a novel mutant strain of D. brucei, which was deposited on January 9, 2003 in the Republic of China Food Industry Development Institute for biological resources conservation and researching Heart, registered D. serrata, BCRC 920084.
實施例 Example
A.材料與方法 A. Materials and methods
(A)材料 (A) material
1.標準品: 1. Standard product:
白藜蘆醇及糖苷為購自Aldrich公司。 Resveratrol and glycosides were purchased from Aldrich.
2.試劑及培養基: 2. Reagents and culture media:
酵母抽出物蛋白腖葡萄糖培養基(yeast extract peptone dextrose medium,YPD)、乙酸(acetic acid)、醋酸鈉(sodium acetate)、乙醇(ethanol)、氯仿(chloroform)、乙酸乙酯(ethyl acetate)、苯(benzene)、乙醚(ethyl ether)、甲苯(toluene、正己烷(hexane)、乙腈(acetonitrile)、pNP、pNPG、NaCl、NH4Cl、Na2CO3、葡萄糖(glucose)、麥芽糖(maltose)、乳糖(lactose)、KNO3、NH4NO3、(NH4)2SO4、酵母抽出物(yeast extract)、蛋白腖(peptone)、MgSO4、KCl、Tween 80等為購自Merck公司。 Yeast extract peptone dextrose medium (YPD), acetic acid, sodium acetate, ethanol, chloroform, ethyl acetate, benzene ), ethyl ether, toluene, hexane, acetonitrile, pNP, pNPG, NaCl, NH 4 Cl, Na 2 CO 3 , glucose, maltose, lactose ( lactose), KNO 3, NH 4 NO 3, (NH 4) 2 SO 4, aspirate yeast (yeast extract), peptone (peptone), MgSO 4, KCl , Tween 80 , etc. available from the company Merck.
3.儀器 3. Instrument
各種溫度之培養箱、電磁加熱攪拌器、高效液相層析(high-performance liquid chromatography,HPLC)、分光光度計、5公升發酵槽、20公升發酵槽、冷凍乾燥機、迴旋濃縮機、大型蒸汽式濃縮機、版框壓濾機、直立式壓濾機等。 Incubator of various temperatures, electromagnetic heating stirrer, high-performance liquid chromatography (HPLC), spectrophotometer, 5 liter fermentation tank, 20 liter fermentation tank, freeze dryer, cyclone concentrator, large steam Concentrator, frame filter press, vertical filter press, etc.
(B)方法 (B) method
1.搖瓶培養: 1. Shake flask culture:
將菌接種於酵母抽出物蛋白腖葡萄糖培養基,並以150rpm,25℃進行培養形成菌液。當菌液之OD600值達到10時,於一培養基 (例如,醋酸緩衝液(1M~5mM,pH 4.5~6.5))中,加入上述菌液(添加量為培養基體積之5%)與白藜蘆醇前驅物或含有白藜蘆醇前驅物的一植物基質(添加量為培養基體積之5%),並於150rpm,25℃進行發酵24小時。之後將培養液進行凍乾、80%酒精萃取後,以高效液相層析來分析糖苷及白藜蘆醇含量。 The bacteria were inoculated into a yeast extract peptone glucose medium, and cultured at 150 rpm and 25 ° C to form a bacterial solution. When the OD 600 value of the bacterial solution reaches 10, in the medium (for example, acetate buffer (1M ~ 5mM, pH 4.5 ~ 6.5)), the above bacterial solution (added amount is 5% of the medium volume) and chalk A ruthenium precursor or a plant substrate containing a resveratrol precursor (added in an amount of 5% by volume of the medium) was subjected to fermentation at 150 rpm, 25 ° C for 24 hours. After the culture solution was lyophilized and extracted with 80% alcohol, the glycosidic and resveratrol contents were analyzed by high performance liquid chromatography.
2.菌株之β-葡萄糖苷酶的活性測定 2. Determination of β-glucosidase activity of the strain
(1)將pNP以1M Na2CO3配成不同濃度,並以分光光度計測各濃度之pNP於OD 405nm之吸光值以做為檢量線。 (1) pNP was formulated into different concentrations with 1 M Na 2 CO 3 , and the absorbance of each concentration of pNP at OD 405 nm was measured spectrophotometrically as a calibration curve.
(2)將待測菌株進行培養,並於不同時間取樣分析。 (2) The strain to be tested is cultured and sampled and analyzed at different times.
(3)將菌液分成兩部份。一部份以100℃加熱5分鐘使於其中之酵素失去活性後,將其冷卻離心並取上清液1mL至透明玻璃管中做為空白對照組;而另一部份則為將其離心並取上清液1mL至透明玻璃管做為實驗組。 (3) Dividing the bacterial liquid into two parts. After a part of the enzyme was deactivated by heating at 100 ° C for 5 minutes, it was cooled and centrifuged, and 1 mL of the supernatant was taken to a transparent glass tube as a blank control group; and the other part was centrifuged and 1 mL of the supernatant was taken to a transparent glass tube as an experimental group.
(4)將對照組及實驗組分別加入10mM的pNPG(溶於20mM醋酸緩衝液,pH5)1mL,接著於50℃加熱並攪拌30分鐘以進行反應以形成一反應溶液。之後於反應溶液中加入2mL冰1M Na2CO3以終止反應。然後,將反應溶液混合均勻後,取一部份測定其OD 405nm之吸光值。若所測得吸光值超過檢量線之範圍,則以對照組作稀釋後測,並依檢量線推其酵素活性。 (4) The control group and the experimental group were separately added with 10 mM of pNPG (dissolved in 20 mM acetate buffer, pH 5) 1 mL, followed by heating at 50 ° C and stirring for 30 minutes to carry out a reaction to form a reaction solution. Thereafter, 2 mL of ice 1 M Na 2 CO 3 was added to the reaction solution to terminate the reaction. Then, after the reaction solution was uniformly mixed, a part thereof was measured for its absorbance at OD 405 nm. If the measured absorbance exceeds the range of the calibration curve, the control is diluted and measured, and the enzyme activity is pushed according to the calibration curve.
3.甲基硝基亞硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,NTG)突變 3. N-methyl-N ' -nitro-N-nitrosoguanidine (NTG) mutation
根據先前試驗得知,以100ppm的甲基硝基亞硝基胍處理菌株5分鐘來產生突變具有較佳結果,於是將布魯塞爾德克酵母菌(Dekkera bruxellensis)BCRC 21440先以不同濃度的甲基硝基亞硝 基胍處理5分鐘以產生突變。結果顯示,經100ppm的甲基硝基亞硝基胍處理5分鐘之布魯塞爾德克酵母菌BCRC 21440其致死率為約58%。於是重新將布魯塞爾德克酵母菌BCRC 21440以100ppm的甲基硝基亞硝基胍進行不同時間長度的處理。結果顯示,隨甲基硝基亞硝基胍處理時間增加,菌株致死率增加。於處理20分鐘後,菌株之致死率達70%,但之後隨著處理時間的延長,致死率則呈趨緩。另外,重新配置不同濃度之甲基硝基亞硝基胍,並布魯塞爾德克酵母菌BCRC 21440分別以不同濃度的甲基硝基亞硝基胍處理5分鐘以進行突變。結果顯示,隨甲基硝基亞硝基胍濃度增加,菌株之致死率提昇。當甲基硝基亞硝基胍濃度為300ppm時,菌株之致死率達70%,但之後隨著處理濃度的增加,致死率則呈趨緩。 According to previous experiments, it was found that the strain was treated with 100 ppm of methylnitronitrosoguanidine for 5 minutes to produce a mutation with better results, so that Dekkera bruxellensis BCRC 21440 was first treated with different concentrations of methyl nitrate. The nitrosoguanidine was treated for 5 minutes to generate a mutation. The results showed that the lethality rate of D. cerevisiae BCRC 21440 treated with 100 ppm of methylnitronitroguanidine for 5 minutes was about 58%. The D. sclerophylla BCRC 21440 was then re-treated with 100 ppm of methylnitronitroguanidine for various lengths of time. The results showed that the mortality of the strain increased with the increase of the treatment time of methylnitronitroguanidine. After 20 minutes of treatment, the lethality of the strain reached 70%, but then the mortality rate slowed down as the treatment time prolonged. In addition, different concentrations of methylnitronitroguanidine were reconfigured and D. brucei BCRC 21440 was treated with different concentrations of methylnitronitroguanidine for 5 minutes for mutation. The results showed that as the concentration of methylnitronitroguanidine increased, the lethality of the strain increased. When the concentration of methylnitronitroguanidine was 300 ppm, the lethality of the strain reached 70%, but then the mortality rate slowed down as the treatment concentration increased.
甲基硝基亞硝基胍突變之實驗方法如下所述:(i)將菌株活化;(ii)將經活化之菌株轉移至培養液;(iii)培養16-24小時之後,以8000rpm將培養液離心5分鐘以收菌;(iv)去除上清液,將沉澱物以等量PBS緩衝溶液回溶清洗3次;(v)將菌液濃度調整為106CFU/mL左右;(vi)將菌液與甲基硝基亞硝基胍混合(不同濃度之甲基硝基亞硝基胍或不同之處理時間);(vii)將菌液離心以去除上清液,之後將沉澱物以等量PBS緩衝溶液清洗3次;(viii)將菌液進行適量之稀釋,並塗佈於平板培養基上以進行 培養;(ix)挑選菌株以進行其β-葡萄糖苷酶的活性測定;(x)將β-葡萄糖苷酶的活性較佳之菌株再進行突變或進行穩定性分析。 The experimental method of methylnitronitroguanidine mutation is as follows: (i) activation of the strain; (ii) transfer of the activated strain to the culture solution; (iii) culture for 16-24 hours, culture at 8000 rpm The solution was centrifuged for 5 minutes to collect bacteria; (iv) the supernatant was removed, and the precipitate was washed back three times with an equal amount of PBS buffer solution; (v) the concentration of the bacterial solution was adjusted to about 10 6 CFU/mL; (vi) Mixing the bacterial solution with methylnitronitroguanidine (different concentrations of methylnitronitroguanidine or different treatment time); (vii) centrifuging the bacterial liquid to remove the supernatant, and then depositing the precipitate An equal amount of PBS buffer solution was washed 3 times; (viii) the bacterial solution was diluted in an appropriate amount and applied to the plate medium for culture; (ix) the strain was selected for its β-glucosidase activity assay; The strain with better β-glucosidase activity is further mutated or subjected to stability analysis.
將經挑選之甲基硝基亞硝基胍處理突變株調整菌體濃度後,接種至96孔ELISA盤中,培養24小時。之後取出上清液加入pNPG及Na2CO3呈色,以ELISA讀取儀判讀其OD 405nm之值,並將此值與原始菌株相較,以選擇β-葡萄糖苷酶(β-glucosidase)產量較好的菌株。將所選擇之β-葡萄糖苷酶產量較好的菌株以ELISA讀取儀進行β-葡萄糖苷酶之穩定性分析,若同個樣本經多次測量,ELISA之讀值穩定,顯示菌株突變後分泌β-葡萄糖苷酶性狀穩定。 The selected methylnitronitroguanidine-treated mutant was adjusted to the bacterial concentration, and then inoculated into a 96-well ELISA plate and cultured for 24 hours. Then, the supernatant was taken out and added with pNPG and Na 2 CO 3 color, and the value of OD 405 nm was read by an ELISA reader, and this value was compared with the original strain to select β-glucosidase production. A better strain. The strain with better β-glucosidase yield was analyzed by ELISA reader for β-glucosidase stability. If the same sample was measured multiple times, the ELISA reading value was stable, indicating that the strain was secreted and secreted. The β-glucosidase trait is stable.
4.植物基質之製備、白藜蘆醇之微生物轉化生產及轉化率之計算 4. Preparation of plant substrate, microbial conversion production of resveratrol and calculation of conversion rate
(1)將虎杖、石榴皮等植物基質以果汁機攪碎備用。 (1) Plant bases such as Polygonum cuspidatum and pomegranate peel are grounded in a juice machine for use.
(2)將菌株以酵母抽出物蛋白腖葡萄糖培養基培養基活化。之後將菌株加入含植物基質培養基中以使基質進行轉化,並不同時間點進行收集樣品。 (2) The strain was activated with yeast extract peptone glucose medium. The strain is then added to the plant-containing substrate medium to allow the matrix to be transformed, and samples are collected at different time points.
(3)樣品進行凍乾,之後加入50%乙醇並於70℃以超音波輔助萃取30分鐘。將所萃取之萃取液冷卻後以0.22um濾膜過濾。 (3) The sample was lyophilized, followed by addition of 50% ethanol and ultrasonically assisted extraction at 70 ° C for 30 minutes. The extracted extract was cooled and filtered through a 0.22 um filter.
(4)然後以高效液相層析來分析濾液之虎杖糖苷(piceid)與白藜蘆醇(resverotrol)含量,並計算虎杖糖苷轉化為白藜蘆醇之轉化率。 (4) The content of piceid and resverotrol in the filtrate was analyzed by high performance liquid chromatography, and the conversion rate of polydatin to resveratrol was calculated.
M:莫耳數 M: Moir number
5.白藜蘆醇的萃取: 5. Extraction of resveratrol:
(1)將經凍乾之含轉化後植物基質的培養基加入1:10之80%酒精(w/w)並進行30分鐘超音波(40kHz)震盪。以此步驟進行兩次萃取;(2)合併萃取液並進行乾燥。以1:10進行覆水(w/w)形成溶液,再以1:1之比例將乙醚加入此溶液中,之後收集乙醚層,以此步驟進行兩次萃取;(3)將乙醚層進行乾燥得白藜蘆醇產物。 (1) The lyophilized medium containing the transformed plant substrate was added to 1:10 of 80% alcohol (w/w) and subjected to ultrasonic (40 kHz) shaking for 30 minutes. Two extractions were carried out in this step; (2) the extracts were combined and dried. The solution was formed by water (w/w) at 1:10, and then diethyl ether was added to the solution in a ratio of 1:1, and then the ether layer was collected, and the extraction was carried out twice; (3) the ether layer was dried. Resveratrol product.
6.糖苷與白藜蘆醇的分析: 6. Analysis of glycosides and resveratrol:
(1)分別取糖苷與白藜蘆醇標準品,以50%酒精將其分別配製成0.5、5、25、75、100、150與175mg/L濃度並以HPLC分析,以獲得其分別之檢量線;(2)將萃取後樣品稀釋至檢量線濃度內,以0.22μm濾膜過濾後,以HPLC分析白藜蘆醇及糖苷含量;(3)HPLC分析以C18管柱4.6x250nm,5μm(Waters ODS II)作為分離管柱進行分析;(4)移動相為A:0.1%乙酸;B:乙腈。初始以95%A與5%B,25.3分鐘後轉為55%之A與45%之B,31分鐘轉為100%之B,33分鐘後調回初始值95%之A與5%之B,維持至45分鐘; (5)移動相流速為1.5mL/分鐘,樣品注射量為20μL。 (1) Take the glycosidic and resveratrol standards, respectively, and prepare them at concentrations of 0.5, 5, 25, 75, 100, 150 and 175 mg/L with 50% alcohol and analyze them by HPLC to obtain their respective The calibration curve; (2) diluting the sample after extraction into the concentration of the calibration line, filtering with 0.22 μm filter, analyzing the content of resveratrol and glycoside by HPLC; (3) HPLC analysis with C 18 column 4.6×250 nm 5 μm (Waters ODS II) was analyzed as a separation column; (4) the mobile phase was A: 0.1% acetic acid; B: acetonitrile. Initially with 95% A and 5% B, after 25.3 minutes, it is converted to 55% A and 45% B, 31 minutes to 100% B, and after 33 minutes, the initial value is 95% A and 5% B , maintained to 45 minutes; (5) mobile phase flow rate of 1.5mL / min, sample injection volume of 20μL.
B.實驗與結果 B. Experiments and results
1.菌株之轉化基質生成白藜蘆醇之能力的分析 1. Analysis of the ability of strain transformation matrix to produce resveratrol
(1)菌株之初步篩選 (1) Preliminary screening of strains
首先由生資中心微生物資源庫進行初步篩選,初步篩選出如表1所示之細菌、酵母菌及絲狀真菌。並將其分別進行培養與β-葡萄糖苷酶的活性測試。 Firstly, preliminary screening was carried out by the microbial resource pool of the Biomass Center, and the bacteria, yeast and filamentous fungi as shown in Table 1 were initially screened. They were separately cultured and tested for β -glucosidase activity.
於測定各菌株之β-葡萄糖苷酶表現後,篩選出表現β-葡萄糖苷酶較高的微生物菌株,其分別為2株酵母菌,為布魯塞爾德克酵母菌(Dekkera bruxellensis)BCRC 21440與啤酒釀母菌(Saccharomyces cerevisiae)BCRC 20855,以及9株真菌,為黑黴菌(Aspergillus niger)BCRC 32734與BCRC 30883、百脈根輪紋菌(Stemphylium loti)BCRC 31890、疣孢漆斑黴(Myrothecium verrucaria)BCRC 31545、米麴菌(Aspergillus oryzae)BCRC 30230與BCRC 32271以及嗜熱側孢黴菌(Sporotrichum thermophile)BCRC 31852。 After measuring the β-glucosidase performance of each strain, a strain of microorganisms exhibiting high β-glucosidase was selected, which were respectively 2 yeasts, which were Dekkera bruxellensis BCRC 21440 and brewed with beer. Saccharomyces cerevisiae BCRC 20855 , and 9 strains of fungi, Aspergillus niger BCRC 32734 and BCRC 30883, Stemphylium loti BCRC 31890, Myrothecium verrucaria BCRC 31545, Aspergillus oryzae BCRC 30230 and BCRC 32271, and Sporotrichum thermophile BCRC 31852.
2.菌株之轉化基質生成白藜蘆醇之能力的分析 2. Analysis of the ability of strain transformation matrix to produce resveratrol
對於所篩選出之各菌株進行下述之實驗。將作為植物基質之虎杖或石榴皮的粉末以及一菌株加入水中,並進行發酵。於發酵之後將培養液加入80%乙醇以進行萃取。將所獲得之萃取液以HPLC分析白藜蘆醇及糖苷之含量。使用虎杖為基質之各菌株的實驗結果如第1A圖所示,而使用石榴皮為基質之各菌株的實驗結果如第1B圖所示。 The following experiments were carried out for each of the selected strains. A powder of a Polygonum cuspidatum or pomegranate peel as a plant substrate and a strain are added to water and fermented. After the fermentation, the culture solution was added to 80% ethanol for extraction. The obtained extract was analyzed for the content of resveratrol and glycoside by HPLC. The experimental results of each strain using the Polygonum cuspidatum as the substrate are shown in Fig. 1A, and the experimental results of the respective strains using the pomegranate peel as the substrate are shown in Fig. 1B.
根據第1A與1B圖之結果,可以清楚得知,相同之菌株對於不同之植物基質的白藜蘆醇及糖苷含量的增加或減少能力不同,且不同之菌株對於相同之植物基質的白藜蘆醇及糖苷含量的增減情況也不相同。而根據整個實驗結果初步看來,以酵母菌之布魯塞爾德克酵母菌(Dekkera bruxellensis)BCRC21440對於白藜蘆醇之生成具有較佳轉化基質生成白藜蘆醇的效果。 According to the results of Figures 1A and 1B, it can be clearly seen that the same strain has different ability to increase or decrease the resveratrol and glycoside content of different plant substrates, and different strains for the same plant substrate of white gourd The increase and decrease of alcohol and glycoside content are also different. According to the results of the whole experiment, it is preliminarily that the yeast Dekkera bruxellensis BCRC21440 has a better effect of transforming resveratrol to produce resveratrol.
3.不同之布魯塞爾德克酵母菌(Dekkera bruxellensis)菌株之轉化基質生成白藜蘆醇之能力的分析 3. Analysis of the ability of different transformation substrates of Dekkera bruxellensis strain to produce resveratrol
由上述菌株轉化測試結果顯示,酵母菌之布魯塞爾德克酵母菌BCRC 21440對於白藜蘆醇之生成具有較佳轉化基質生成白藜蘆醇的效果,因此嘗試蒐集不同布魯塞爾德克酵母菌之菌株,其分別為布魯塞爾德克酵母菌BCRC 21440、布魯塞爾德克酵母菌BCRC 20932、布魯塞爾德克酵母菌BCRC 21518、布魯塞爾德克酵母菌BCRC 21519與布魯塞爾德克酵母菌BCRC 21517,並將所蒐集到的菌株以虎杖作為植物基質進行轉化生成白藜蘆醇的試驗。轉化結果如第2圖所示。 The results of the above-mentioned strain transformation test showed that the yeast D. cerevisiae BCRC 21440 had a better effect of producing resveratrol for the production of resveratrol, and therefore attempted to collect different strains of D. serrata, They are D. brucei BCRC 21440, D. serrata BCRC 20932, D. serrata BCRC 21518, D. serrata BCRC 21519 and D. serrata BCRC 21517, and the collected strains The test of transforming resveratrol with Polygonum cuspidatum as a plant substrate. The conversion results are shown in Figure 2.
根據第2圖可知,所蒐集之布魯塞爾德克酵母菌對於虎杖基質皆具有良好轉化基質生成白藜蘆醇之能力,而後續以布魯塞爾德克酵母菌BCRC 21440菌株進行進一步突變以提升其轉化基質生成白藜蘆醇之能力。 According to Fig. 2, the collected D. serrata has a good ability to transform the matrix to produce resveratrol for the Polygonum cuspidatum substrate, and the subsequent mutation with D. brucei BCRC 21440 strain to enhance its transformation matrix production. The ability of resveratrol.
虎杖中糖苷含量約為白藜蘆醇之2-4倍,較其他植物基質高很多,故利用虎杖作為菌株轉化的植物基質,可得到較佳的白藜蘆醇產量,且有助於後續純化回收白藜蘆醇。 The content of glycosides in Polygonum cuspidatum is about 2-4 times higher than that of resveratrol, which is much higher than other plant substrates. Therefore, using Polygonum cuspidatum as the plant substrate transformed by the strain can obtain better yield of resveratrol and facilitate subsequent purification. Resveratrol is recovered.
4.布魯塞爾德克酵母菌BCRC 21440之甲基硝基亞硝基胍(N-methyl-N'-nitro-N-nitrosoguanidine,NTG)突變 4. N-methyl-N ' -nitro-N-nitrosoguanidine (NTG) mutation of Dick's yeast BCRC 21440
將布魯塞爾德克酵母菌BCRC 21440經由一連串系列NTG突變後,共挑選226株突變株進行分析,結果以其中12株結果較佳,其分別為編號11、16、34、39、41、53、58、61、63、67、70與72之突變株,於是進一步分別分析此12株突變株於不同培養時間點所產生之β-葡萄糖苷酶(β-glucosidase)的量。結果如第3圖所示。 A total of 226 mutant strains were selected and analyzed by a series of NTG mutations. The results of 12 strains were better, which were number 11, 16, 34, 39, 41, 53, 58 respectively. The mutants of 61, 63, 67, 70 and 72 were further analyzed for the amount of β-glucosidase produced by the 12 mutant strains at different culture time points. The result is shown in Figure 3.
根據第3圖所示可知,上述之12株突變株的β-葡萄糖 苷酶產量均較原始菌株佳,其中又以編號11、53、61及72之突變株較佳。 According to Fig. 3, the β-glucose of the above 12 mutant strains is known. The glycosidase yield was better than that of the original strain, and the mutant strains numbered 11, 53, 61 and 72 were preferred.
之後,將上述編號11、53、61及72之突變株所產生之β-葡萄糖苷酶進行穩定性分析。將每株挑選23個菌落並調整至相同OD值後,培養48小時。之後測定所培養之菌的OD405吸光值,分析其穩定性。結果顯示4株菌產β-葡萄糖苷酶能力差異不大,而編號11之突變株產β-葡萄糖苷酶能力的變異性較大(>10%),其他3株都在10%以下,此外,由於編號72號之突變株的β-葡萄糖苷酶產量略高,因此將其作為後續培養基探討之菌株,並將其命名為布魯塞爾德克酵母菌(Dekkera bruxellensis)NTG-72,且於中華民國102年1月9日寄存於中華民國食品工業發展研究所生物資源保存及研究中心,寄存編號為BCRC 920084,並於2013年7月11日寄存於德國微生物菌種保存中心(Deutsche Sammlung von Mikroorganismen und Zellkulturen,DSMZ),寄存編號為DSM 27483。 Thereafter, the β-glucosidase produced by the mutants of the above Nos. 11, 53, 61 and 72 was subjected to stability analysis. After selecting 23 colonies per plant and adjusting to the same OD value, the cells were cultured for 48 hours. Thereafter, the OD 405 absorbance of the cultured bacteria was measured, and the stability was analyzed. The results showed that the ability of the four strains to produce β-glucosidase was not much different, while the mutant strain No. 11 had a greater variability in the production of β-glucosidase (>10%), and the other three strains were all below 10%. Since the β-glucosidase production of the No. 72 mutant was slightly higher, it was used as a strain for the subsequent medium, and it was named Dekkera bruxellensis NTG-72, and it was in the Republic of China. Deposited at the Bioresource Conservation and Research Center of the Republic of China Food Industry Development Institute on January 9, 102, with the registration number BCRC 920084, and deposited at the German Collection of Microbial Species (Deutsche Sammlung von Mikroorganismen und) on July 11, 2013 Zellkulturen, DSMZ), registration number DSM 27483.
連續培養之菌株的轉化基質生成白藜蘆醇之能力的分析 Analysis of the ability of the transformed substrate of continuous culture to produce resveratrol
經由一連串篩選與突變篩選,以上述編號72號之突變株進行後續實驗。以YPD培養基進行種菌活化,之後將經活化種菌接種並培養,當其以OD600測定值達到10,再進行後續轉化試驗。 Subsequent experiments were carried out with the above-mentioned No. 72 mutant strain through a series of screening and mutation screening. The inoculum activation was carried out in YPD medium, and then the activated inoculum was inoculated and cultured, and when it was measured at an OD 600 of 10, a subsequent transformation test was carried out.
(1)5公升之發酵槽連續培養 (1) Continuous fermentation of a 5 liter fermentation tank
利用5公升發酵槽並以虎杖為植物基質來培養編號72號之突變株進行生產白藜蘆醇,而培養條件為:25℃、100~200 rpm、通氣量為1vvm、5%接菌量(相對於培養基之體基)。分別以福格爾最小鹽類培養基(Vogel minimal salts medium,VMSM)、20mM醋酸緩衝液pH 5.0與水作為生產的培養基,添加2%虎杖(相對於培養基之體基)作為轉化白藜蘆醇的植物基質來培養編號72號之突變株,結果如第4A圖所示。 The mutant strain No. 72 was cultured using a 5 liter fermenter and using Polygonum cuspidatum as a plant substrate to produce resveratrol, and the culture conditions were: 25 ° C, 100 to 200 Rpm, aeration volume of 1 vvm, 5% inoculation amount (relative to the body base of the medium). 2% Polygonum cuspidatum (relative to the body base of the medium) was added as a medium for conversion of resveratrol with Vogel minimal salts medium (VMSM), 20 mM acetate buffer pH 5.0 and water as the production medium. The plant substrate was used to culture the mutant No. 72, and the results are shown in Fig. 4A.
第4A圖顯示,以醋酸緩衝液作為培養基具有最高之白藜蘆醇產量。最高的白藜蘆醇的含量為7455.6μg/g,之後隨時間的增加而緩慢降低,而此時的虎杖糖苷含量只剩下198.6μg/g,而其次為水作為培養基,最差的為福格爾最小鹽類培養基。 Figure 4A shows that the highest yield of resveratrol was obtained with acetate buffer as the medium. Highest concentrations of resveratrol of 7455.6 μ g / g, and then gradually decreases with increasing time, but this time only the content of glycosides Polygonum 198.6 μ g / g, and followed by water as a medium, the worst For Fogel's smallest salt medium.
(2)20公升之發酵槽連續培養 (2) Continuous fermentation of 20 liter fermentation tank
利用20公升發酵槽與並以虎杖為植物基質來培養編號72號之突變株進行生產白藜蘆醇,以100-200rpm、0.2vvm的條件進行培養。以20mM醋酸緩衝液pH5.0作為培養基,並添加2%虎杖(相對於培養基之體基)作為基質,結果第4B圖所示。 The mutant strain No. 72 was cultured using a 20-liter fermentation tank and a Polygonum cuspidatum as a plant substrate to produce resveratrol, and cultured at 100-200 rpm and 0.2 vvm. 20 mM acetate buffer pH 5.0 was used as the medium, and 2% of Polygonum cuspidatum (relative to the body base of the medium) was added as a substrate, and the results are shown in Fig. 4B.
第4B圖顯示,白藜蘆醇含量隨時間而增加,直到40小時趨於平緩,從2177.6ug/g增加到最高值為7266.4ug/g,而虎杖糖苷的趨勢則相反。另外,計算虎杖糖苷轉化成白藜蘆醇的轉化率,結果轉化率可以達到95%以上。 Figure 4B shows that resveratrol content increased over time, tended to be flat until 40 hours, increasing from 2177.6 ug/g to a maximum of 7266.4 ug/g, while the trend of polydatin was reversed. In addition, the conversion rate of polydatin to resveratrol was calculated, and the conversion rate was 95% or more.
綜合前述結果可知,將β-葡萄糖苷酶高產量之酵母菌(編號72號之突變株)以虎杖為植物基質進行發酵,以轉化虎杖糖苷生成白藜蘆醇。從搖瓶初步測試轉化率、5公升發酵槽測試轉速及通氣量參數、20公升發酵槽測試放大製程之轉化率均可行後,共進行多次發酵(包括5公升、20公升、250公升和2000公升,均進行三次以上)。結果顯示,在所有發酵體積之實驗中,在培養 第30-72小時期間,糖苷含量降至0.5mg/g或以下,而白藜蘆醇從30小時後則漸趨於穩定,大約含量為8-12mg/g,其轉化率更可達95%以上。 Based on the above results, it was found that a yeast having a high yield of β-glucosidase (a mutant strain No. 72) was fermented with Polygonum cuspidatum as a plant substrate to transform a polydatin to form resveratrol. The initial conversion rate of the shake flask, the test speed of the 5 liter fermentation tank and the aeration parameter, and the conversion rate of the 20 liter fermentation tank test amplification process are all possible, including multiple fermentations (including 5 liters, 20 liters, 250 liters, and 2000). The liters are carried out more than three times). The results show that in all experiments of fermentation volume, in culture During the 30-72 hour period, the glycoside content decreased to 0.5 mg/g or less, and resveratrol gradually stabilized after 30 hours, about 8-12 mg/g, and the conversion rate was 95%. the above.
國內寄存資訊【請依寄存機構、日期、號碼順序註記】 Domestic registration information [please note according to the registration authority, date, number order]
中華民國食品工業發展研究所生物資源保存及研究中心、102/1/9、BCRC 920084(寄存證明已於本申請案之母案,申請號103107359中呈送在案) Center for the Conservation and Research of Biological Resources of the Republic of China Food Industry Development Institute, 102/1/9, BCRC 920084 (the registration certificate has been filed in the parent of this application, application number 103107359)
國外寄存資訊【請依寄存機構、日期、號碼順序註記】 Foreign deposit information [please note according to the registration authority, date, number order]
德國微生物菌種保存中心(Deutsche Sammlung von Mikroorganismen und Zellkulturen,DSMZ)、2013/7/11、DSM 27483(寄存證明已於本申請案之母案,申請號103107359中呈送在案) German microbial strain preservation center (Deutsche Sammlung von Mikroorganismen und Zellkulturen, DSMZ), 2013/7/11, DSM 27483 (the proof of deposit has been filed in the application of this application, application number 103107359)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW104109310A TWI519642B (en) | 2014-03-05 | 2014-03-05 | Novel dekkera bruxellensis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW104109310A TWI519642B (en) | 2014-03-05 | 2014-03-05 | Novel dekkera bruxellensis |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201534716A TW201534716A (en) | 2015-09-16 |
TWI519642B true TWI519642B (en) | 2016-02-01 |
Family
ID=54695114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104109310A TWI519642B (en) | 2014-03-05 | 2014-03-05 | Novel dekkera bruxellensis |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI519642B (en) |
-
2014
- 2014-03-05 TW TW104109310A patent/TWI519642B/en active
Also Published As
Publication number | Publication date |
---|---|
TW201534716A (en) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105112305B (en) | A kind of red yeast rice and preparation method thereof rich in Monacolin K | |
CN111139188A (en) | Novel skeleton heteroterpene derivative derived from marine fungi and application of novel skeleton heteroterpene derivative in preparation of anti-inflammatory drugs | |
CN103224890A (en) | Monascus ruber for high generation of lovastatin and gamma-aminobutyric acid and low generation of pigment, use thereof, and functional Monascus sp. prepared through using Monascus ruber | |
TW201249859A (en) | Use of extraction residue of yeast extract | |
KR20190127572A (en) | Method for producing low-sugar vegetable and fruit enzyme product | |
CN106047713B (en) | The basket bacteria strain Li-93 of one plant of thermophilic pine and its application | |
CN102010831B (en) | Lovastatin-generating fungus and application thereof in production of Pu'er tea | |
KR102258788B1 (en) | Novel Aspergillus niger C2-2 isolated from Nu-ruk producing ginsenoside compound K biotransformation enzyme and use thereof | |
TWI486452B (en) | Method for producing resveratrol through biotransformation by microorganism | |
CN110343625A (en) | A kind of Wine brewing yeast strain and its application | |
CN102433268B (en) | Acetobacter pasteurium and its application method in producing citrus vinegar | |
CN106167781B (en) | A kind of Acetobacter pasteurianus that temperature capacity is excellent and purposes | |
TWI519642B (en) | Novel dekkera bruxellensis | |
CN103981104A (en) | Endophytic fungus and method for biologically converting glycyrrhizic acid into glycyrrhetinic glycoside by using same | |
CN101457250B (en) | Method for synthesizing betulic acid from betulin through microbial cell bioconversion | |
KR102011133B1 (en) | Lactobacillus plantarum MBE/L2990 strain having excellent alpha-rhamnosidase activity and bioconversion activity from ginsenoside Re and Rb1 to ginsenoside Rg1 and Rg5 | |
KR101405052B1 (en) | Manufacture method for red ginseng vinegar | |
CN103073527A (en) | Diterpene Libertellenone G and preparation method and use thereof | |
CN104278070A (en) | Method for improving content of ergosterol in liquid fermentation products of phellinus igniarius | |
CN115927023A (en) | Abnormal yeast Weikehan and application thereof, and wolfberry wine and preparation method thereof | |
CN105602856B (en) | Aspergillus niger (Aspergillus niger) An-19 bacterial strain and its purposes and fermentation process of the production for Lovastatin | |
Wu et al. | Effect of the main ingredients of Rhizoma gastrodiae on mycelial biomass and exopolysaccharide productions by submerged culture of Grifola frondosa | |
CN105838534B (en) | Application of the antibacterial lipopeptid of bacillus subtilis in wine production | |
CN107974476A (en) | A kind of cordycepin is converted into the bioconversion method of 3 '-deoxyinosine | |
AU2020102037A4 (en) | A method of efficiently increasing the alpha-glucosidase inhibitor content in fresh mulberry leaves by the solid-state fermentation |